Abstract #2638

Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI

Alina Tudorica¹, Karen Y Oh¹, Stephen Y-C Chui¹, Nicole Roy¹, Megan L Troxell¹, Arpana Naik¹, Kathleen Kemmer¹, Yiyi Chen¹, Megan L Holtorf¹, Aneela Afzal¹, Charles S Springer, Jr¹, Xin Li¹, and Wei Huang¹

¹Oregon Health & Science University, Portland, OR, United States

DCE-MRI was performed in 28 breast cancer patients (29 tumors) before, during, and after neoadjuvant chemotherapy (NACT). Several DCE-MRI pharmacokinetic (PK) parameters were found to be good early predictors of pathologic complete response (pCR) vs. non-pCR after only one NACT cycle. In addition, several PK parameters and tumor size were significantly correlated with pathologically measured residual cancer burden (RCB).

This abstract and the presentation materials are available to members only; a login is required.

Join Here